Precision medicine

New technologies such as digital pathology give the lab opportunities to grow and center itself in the patient care journey

How to choose the right biomarker test for success in precision oncology

A new liquid biopsy test can allow easier, more accurate diagnosis of malignancy in patients who are predisposed to cancer

An expert panel discusses current progress and future possibilities to collaborate in the field of targeted therapy in lung cancer

Brandon S. Sheffield shares his experience with onboarding in-house NGS testing – and why he thinks everyone should follow suit

Big data is key to precision medicine, but presents a stumbling block for analysis – can machine learning help us overcome this hurdle?

Integrated pediatric leukemia risk stratification and relapse prediction

Umberto Malapelle discusses his lab’s experience with onboarding precision medicine – and how other laboratories can follow in their footsteps

Six reasons the KRAS G12C mutation matters

Personalized treatments have the greatest potential to benefit cancer patients.